Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 11 2020

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-11-2020-1

Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 11, 2020, titled "Zydus Cadila receives its first complex injectable approval from USFDA for Doxorubicin Hydrochloride Liposome Injection".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases